GROY vs SLDB
Comparison between Gold Royalty Corp (GROY, Company) and Solid Biosciences Inc (SLDB, Company).
GROY is from the Basic Materials sector, while SLDB is from the Healthcare sector.
5-Year PerformanceGROY has outperformed SLDB, delivering a return of -9.7% compared to -35.0%
GROY vs SLDB - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
GROY vs SLDB - Historical Returns
Returns include dividend reinvestment.
GROY vs SLDB - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | GROY | SLDB |
|---|---|---|
| 2026 | -29.29% | +31.01% |
| 2025 | +225.81% | +44.62% |
| 2024 | -16.55% | -36.00% |
| 2023 | -40.37% | +9.25% |
| 2022 | -52.08% | -79.85% |
| 2021 | +37.43% | -77.68% |
| 2020 | N/A | +71.11% |
| 2019 | N/A | -84.61% |
| 2018 | N/A | +18.48% |
GROY vs SLDB Drawdown Comparison
The maximum drawdown for GROY was -82.01%, occurring on Dec 23, 2024. This drawdown has not yet recovered.
The maximum drawdown for SLDB was -99.76%, occurring on Oct 27, 2023. This drawdown has not yet recovered.
The current GROY drawdown is -55.64%. The current SLDB drawdown is -99.08%.
| Rank | GROY | SLDB |
|---|---|---|
| #1 | -82.01% Jun 24, 2021 - Dec 23, 2024 | -99.76% Sep 20, 2018 - Oct 27, 2023 |
| #2 | -17.97% Jun 14, 2021 - Jun 22, 2021 | -78.32% Mar 2, 2018 - Jun 19, 2018 |
| #3 | -10.60% Mar 12, 2021 - May 24, 2021 | -19.47% Jun 25, 2018 - Jul 18, 2018 |
| #4 | -7.50% May 24, 2021 - Jun 14, 2021 | -17.72% Feb 2, 2018 - Feb 23, 2018 |
| #5 | -1.46% Mar 10, 2021 - Mar 12, 2021 | -17.05% Jun 19, 2018 - Jun 25, 2018 |
| #6 | N/A | -15.12% Jul 19, 2018 - Sep 4, 2018 |
| #7 | N/A | -11.65% Sep 12, 2018 - Sep 20, 2018 |
| #8 | N/A | -11.54% Sep 4, 2018 - Sep 12, 2018 |
| #9 | N/A | -5.06% Jan 29, 2018 - Jan 31, 2018 |
| #10 | N/A | -3.20% Feb 26, 2018 - Mar 1, 2018 |
Correlation
Correlation between GROY and SLDB is 0.64 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks